Antihypertensive drugs use over a 5-year period among children and adolescents in Beijing, China

Wu, Yao; Cao, Yaying; Song, Jing; Tian, Yaohua; Wang, Mengying; Li, Man; Wang, Xiaowen; Huang, Ze; Li, Lin; Zhao, Yaling; Qin, Xueying; Hu, Yonghua

doi:10.1097/md.0000000000017411

Cited by 3 publications

(2 citation statements)

References 29 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Ma et al [6] stated that β-Blocker prescribing during outpatient visits for uncomplicated hypertension was high and increased modestly from 24% in 1993 to 33% in 2004 in the United States [6]. Wu et al [7] reported that among children and adolescents in Beijing, China the trends of prescribing beta-blockers increased from 2010 to 2014 and that beta-blockers and angiotensinconverting enzyme inhibitors were more likely to be prescribed in outpatient visits [7]. Ahmed et al [8] reported that about 18.66% of the antihypertensive classes that were used in the outpatient setting were beta-blockers [8].…”

Section: Between 1 Stmentioning

confidence: 99%

Trends in Beta-Blocker Prescribing in a Public Hospital in Al Saih

Ahmed

2021

JPRI

View full text Add to dashboard Cite

Aim: This study aimed to describe the trends in beta-blocker prescribing in the outpatient setting of a public hospital in Al Saih. Methodology: This is a retrospective study that includes patient electronic records revision of outpatients Between 1st July and 31th December 2018. Results: The most commonly prescribed beta-blocker was bisoprolol (79.10%) followed by metoprolol (7.34%) More than half of the patients were less than 60 years old (52.54%). About 55.93% of the patients receiving beta-blockers were male. About 39.55% of the prescribed drugs were prescribed by cardiology department (39.55%) followed by internal medicine department (36.72%). Conclusion: It can be concluded that beta-blockers were prescribed commonly. More studies are needed to find the prescribing patterns of beta-blockers for treating different indications and to prepare stratified guidelines to treat cardiovascular patients based on their characteristics.

show abstract

Section: Between 1 Stmentioning

confidence: 99%

Trends in Beta-Blocker Prescribing in a Public Hospital in Al Saih

Ahmed

2021

JPRI

View full text Add to dashboard Cite

show abstract

“…Studies from a range of countries showed that the use of antihypertensive medicines has increased steadily over recent decades [22][23][24][25][26]. The decrease in CVD mortality in Europe that has been observed in recent years is attributed to active preventive practices and proper treatment [27,28].…”

Section: Introductionmentioning

confidence: 99%

Trend of Antihypertensive Medicine Use in the Baltic States between 2008 and 2018: A Retrospective Cross-National Comparison

Trečiokienė

Bratčikovienė

Gulbinovič

et al. 2022

Pharmacoepidemiology

View full text Add to dashboard Cite

High blood pressure is a major risk factor contributing to death and disability rates in the Baltic states. The aim of this study was to compare the utilization of antihypertensive medicines in Estonia, Latvia and Lithuania from 2008 to 2018. In this retrospective cross-national comparison, nationally representative wholesale data from the IQVIA National Retail Audit were analyzed. The utilization of inhibitors of the renin–angiotensin system, beta blockers, calcium channel blockers, diuretics and centrally acting antihypertensives by Defined Daily Doses per 1000 inhabitants and day (DDD/TID) was used to calculate utilization. Time series analysis was used to analyze trends. The utilization increased annually by 10.88, 8.04 and 6.42 DDD/TID in Estonia, Latvia and Lithuania, respectively, from 2008. The utilization of antihypertensive drugs in 2018 was 372, 267 and 379.5 DDD/TID, respectively. Inhibitors of the renin–angiotensin system were the most commonly used class in 2008 and 2018. From 2008, the utilization of beta blockers and fixed-dose combinations including renin–angiotensin system inhibitors increased substantially, while that of calcium channel blockers decreased. Country-specific utilization trends were noted; e.g., the utilization of centrally acting antihypertensives was 30.9 DDD/TID in Lithuania compared to 3.01 DDD/TID in Estonia and 16.17 DDD/TID in Latvia. The use of antihypertensive medicines increased over the study period, but the trends for the different drug classes differed between countries.

show abstract

Hypertension in children

Tran

Urbina

2020

Current Opinion in Cardiology

View full text Add to dashboard Cite

Purpose of review Hypertension is a common finding in children, and increases the risk for future cardiovascular events. This review focuses on recent advances in pediatric hypertension research including changes in hypertension guidelines, epidemiology, predictors of hypertension, blood pressure (BP) measurement, effects on target organs, and treatment of hypertension. Recent findings Changes in the 2017 hypertension guidelines by the American Academy of Pediatrics (AAP) have resulted in increased prevalence of elevated BP and hypertension in the United States, and there is no international consensus on these changes. Despite rising pediatric overweight and obesity in China, hypertension prevalence is stable, suggesting multifactorial effects on childhood BP. Maternal diabetes and exposure to particulate matter are associated with higher childhood BP, and body size in infancy and early childhood is a determinant of adult high BP. Children with elevated BP have evidence of target organ damage with altered retinal vasculature and pulse wave velocity parameters compared to normotensive patients. Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers may be the best antihypertensive medications for the pediatric population even for African-American patients. Summary Research continues to illuminate contributors to pediatric hypertension and demonstrates opportunities for further study on the effects of hypertension and its management in children.

show abstract

Antihypertensive drugs use over a 5-year period among children and adolescents in Beijing, China

Abstract: Supplemental Digital Content is available in the text

Cited by 3 publications

References 29 publications

Trends in Beta-Blocker Prescribing in a Public Hospital in Al Saih

Trends in Beta-Blocker Prescribing in a Public Hospital in Al Saih

Trend of Antihypertensive Medicine Use in the Baltic States between 2008 and 2018: A Retrospective Cross-National Comparison

Hypertension in children

Contact Info

Product

Resources

About